Case ReportPubMed ID: 17971653·2007

Case Report: BPC-157 Treatment of Diabetic Foot Ulcer

Marovic A, Tkalcevic G, Dobrivojevic M, et al.

Wound Repair and Regeneration, 2007 · n = 1

Key finding

Grade 3 diabetic ulcer (3cm x 2.5cm) achieved 100% epithelialization within 8 weeks with no recurrence at 18-month follow-up.

Summary

Single patient case report demonstrating complete healing of chronic diabetic foot ulcer (12-year duration) with subcutaneous BPC-157 over 8 weeks.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

BPC-157L2

A gastric pentadecapeptide studied extensively in animal models for tissue healing, gut protection, and cytoprotective properties. Despite over 100 preclinical studies, human clinical data remains extremely limited.

More research on BPC-157

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

Sports Health · 2025 · Review

Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study

Alternative Therapies in Health and Medicine · 2025 · Human Pilot

The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity

Pharmaceuticals · 2024 · Review

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing

Frontiers in Pharmacology · 2021 · Review

Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway

Scientific Reports · 2020 · Animal Study